This intricate involvement of TUG1 in Friedreich's ataxia's neurodegenerative pathology underscores its multifaceted role, emphasizing the need for further exploration of its potential as a biomarker across various stages of the disease. This evidence concerns the gene TUG1 and Friedreich ataxia.